RxDoctor Payments Data

Alan Go

Internal Medicine · Oakland, CANPI 1184700619

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $970 of the $1,256 with a category attached, or 77.2%. E.r. Squibb & Sons, L.L.C. accounts for 77.2% of it on its own, with 2 other manufacturers making up the rest.

$1,256in general payments, 2019–2025

Across 4 payments — averaging $314.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$970
  • Boehringer Ingelheim$193
  • Novartis$93
$1,713,984in research payments, 2019–2025

Across 33 payments — averaging $51,939 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • CSL Behring$1.1M
  • Janssen Research & Development, LLC$313K
  • Gilead$247K
  • Boehringer Ingelheim International GmbH$15K
  • Novartis$3K

What the payments were for

  • Consulting fees$97077%
  • Food & beverage$28623%

General payments by program year

22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,256 in reported general payments places this provider in the 75th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Other internal medicine in Oakland

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →